PLCG2
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
39005deletionPLCG2, 5.9-KB DEL-1MedGen:C3280914,OMIM:614468,Orphanet:ORPHA300359na-1-1nana
39006deletionPLCG2, 8.2-KB DEL-1MedGen:C3280914,OMIM:614468,Orphanet:ORPHA300359na-1-1nana
39007deletionPLCG2, 4.8-KB DEL-1MedGen:C3280914,OMIM:614468,Orphanet:ORPHA300359na-1-1nana
48295single nucleotide variantNM_002661.4(PLCG2):c.2120C>A (p.Ser707Tyr)397514562MedGen:C3553961,OMIM:614878,Orphanet:ORPHA324530168195315481953154CA
48295single nucleotide variantNM_002661.4(PLCG2):c.2120C>A (p.Ser707Tyr)397514562MedGen:C3553961,OMIM:614878,Orphanet:ORPHA324530168191954981919549CA
361601single nucleotide variantNM_002661.4(PLCG2):c.2497G>A (p.Glu833Lys)753762025MedGen:CN221809168192716181927161GA
361601single nucleotide variantNM_002661.4(PLCG2):c.2497G>A (p.Glu833Lys)753762025MedGen:CN221809168196076681960766GA
361664single nucleotide variantNM_002661.4(PLCG2):c.3365T>A (p.Phe1122Tyr)-1MedGen:CN221809168193994381939943TA
361664single nucleotide variantNM_002661.4(PLCG2):c.3365T>A (p.Phe1122Tyr)-1MedGen:CN221809168197354881973548TA
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1681920530rs8055576GTrs80555769.39E-05INTERFERON ALFA-2B|PEGINTERFERON ALFA-2BPOLYETHYLENE GLYCOLS|INTERFERON-ALPHA|IL28B PROTEIN, HUMAN|INTERLEUKINS|RECOMBINANT PROTEINSResponse to hepatitis C treatmentHPOID:0006562DOID:1883AintronGWASdb_drug
1681960958rs3813009GCrs38130094.00E-06IMMUNOGLOBULIN GGLYCOSYLTRANSFERASESIgG glycosylationHPOID:0010701DOID:2531|DOID:417GintronGWASdb_drug
1681960958rs3813009GCrs38130094.00E-07IMMUNOGLOBULIN GGLYCOSYLTRANSFERASESIgG glycosylationHPOID:0010701DOID:2531|DOID:417GintronGWASdb_drug
1681980740rs4284633AGrs42846332.24E-05TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561AintronGWASdb_drug
1681985595rs4889448CTrs48894483.95E-05IMMUNOGLOBULIN GMEX3C PROTEIN, HUMAN|ANTHRAX VACCINES|RNA-BINDING PROTEINS|SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS|ANTIBODIES, BACTERIALImmune response to anthrax vaccineHPOID:0005368DOID:7427TintronGWASdb_drug
1681822707rs11864983AGrs118649836.68E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
1681825054rs12598194CTrs125981941.74E-05Bipolar disorder and schizophreniaHPOID:0007302|HPOID:0100753DOID:3312|DOID:5419CintronGWASdb_trait
1681826853rs4293371GCrs42933716.65E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312CintronGWASdb_trait
1681866586rs4889409GCrs48894091.40E-05Urinary metabolitesHPOID:0000079DOID:557CintronGWASdb_trait
1681870969rs12445050CTrs124450507.80E-06Urinary metabolitesHPOID:0000079DOID:557CintronGWASdb_trait
1681875483rs13334419AGrs133344191.42E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
1681884513rs4497678CGrs44976788.22E-05Type 2 diabetesHPOID:0005978DOID:9352GintronGWASdb_trait
1681887541rs4072683TCrs40726834.26E-04Myocardial InfarctionHPOID:0001658DOID:5844TintronGWASdb_trait
1681902139rs7189843GCrs71898436.00E-05HeightHPOID:0000002NAGintronGWASdb_trait
1681907481rs4888184GArs48881845.63E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
1681907481rs4888184GArs48881842.10E-05Urinary metabolitesHPOID:0000079DOID:557AintronGWASdb_trait
1681920530rs8055576GTrs80555769.39E-05Response to hepatitis C treatmentHPOID:0006562DOID:1883AintronGWASdb_trait
1681924994rs4889428CTrs48894287.82E-04StrokeHPOID:0001297DOID:6713CintronGWASdb_trait
1681941319rs1143689CTrs11436896.06E-05Left ventricular hypertrophyHPOID:0001712DOID:11984Ccds-synonGWASdb_trait
1681955177rs3922849CTrs39228494.27E-05Parkinson's diseaseHPOID:0001300DOID:14330CintronGWASdb_trait
1681955298rs13331678TCrs133316785.31E-05Coronary heart diseaseHPOID:0001677DOID:3393TintronGWASdb_trait
1681958298rs7192724CGrs71927243.00E-06Breast cancer (menopausal hormone therapy interaction)HPOID:0003002DOID:1612CintronGWASdb_trait
1681959191rs17202296GCrs172022962.80E-05Breast cancer (menopausal hormone therapy interaction)HPOID:0003002DOID:1612GintronGWASdb_trait
1681959952rs7201045AGrs72010459.02E-05Ulcerative colitisHPOID:0100279DOID:8577GintronGWASdb_trait
1681960200rs8063604AGrs80636042.77E-05Ulcerative colitisHPOID:0100279DOID:8577AintronGWASdb_trait
1681960365rs12446596CTrs124465962.45E-05Ulcerative colitisHPOID:0100279DOID:8577TintronGWASdb_trait
1681960958rs3813009GCrs38130094.00E-06IgG glycosylationHPOID:0010701DOID:2531|DOID:417GintronGWASdb_trait
1681960958rs3813009GCrs38130094.00E-07IgG glycosylationHPOID:0010701DOID:2531|DOID:417GintronGWASdb_trait
1681963618rs4888190GTrs48881904.50E-05Breast cancer (menopausal hormone therapy interaction)HPOID:0003002DOID:1612TintronGWASdb_trait
1681980740rs4284633AGrs42846332.24E-05Cognitive impairment induced by topiramateHPOID:0100543DOID:1561AintronGWASdb_trait
1681981176rs4312298TGrs43122987.00E-06Alcohol dependenceHPOID:0000707DOID:0050741GintronGWASdb_trait
1681982491rs4889447TCrs48894471.33E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
1681982624rs12444401CGrs124444014.76E-04Multiple complex diseasesHPOID:0000118NACintronGWASdb_trait
1681984437rs4888197AGrs48881971.32E-05Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)HPOID:0001875|HPOID:0001882DOID:1227AintronGWASdb_trait
1681985595rs4889448CTrs48894483.95E-05Parkinson's disease (motor and cognition)HPOID:0001300DOID:14330TintronGWASdb_trait
1681985595rs4889448CTrs48894483.95E-05Immune response to anthrax vaccineHPOID:0005368DOID:7427TintronGWASdb_trait
1681989382rs4888199GCrs48881992.09E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312GintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000197943.9 PLCG2 600220